Latest News

Ten-fraction image-guided hypofractionated radiation therapy could be a feasible treatment option for portal vein tumor thrombosis in patients with HCC.
Hypofractionated RT Shows Portal Vein Tumor Thrombosis Control, OS in HCC

April 29th 2025

Ten-fraction image-guided hypofractionated radiation therapy could be a feasible treatment option for portal vein tumor thrombosis in patients with HCC.

The recommendation from the CHMP is based on results from the phase 2b HERIZON-BTC-01 trial of zanidatamab in advanced HER2+ biliary tract cancer.
Zanidatamab Recommended For Conditional Marketing Approval in Advanced HER2+ BTC

April 29th 2025

According to comparative single-cell transcriptome analyses, NOTCH1 deficiency facilitated a more immunologically active microenvironment in ESCC tumors.
NOTCH1 Mutational Status May Predict ICI Outcomes in Esophageal Cancer

April 28th 2025

MEV01 trial results show that the test achieved an 86% early-stage sensitivity and 88% specificity in surveillance of HCC among patients with cirrhosis.
FDA Grants EvoLiver Biopsy Test Breakthrough Device Designation for HCC

April 23rd 2025

Fruquintinib Combo Exhibits Manageable Safety Profile in Pretreated mCRC
Fruquintinib Combo Exhibits Manageable Safety Profile in Pretreated mCRC

April 22nd 2025

More News